Compare Stocks

3 / 10
Try these comparisons:

Stock Comparison

INGN vs LNTH vs CRVL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
INGN
Inogen, Inc.

Medical - Devices

HealthcareNASDAQ • US
Market Cap$196M
5Y Perf.-81.1%
LNTH
Lantheus Holdings, Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$5.92B
5Y Perf.+562.8%
CRVL
CorVel Corporation

Insurance - Brokers

Financial ServicesNASDAQ • US
Market Cap$2.98B
5Y Perf.+156.6%

INGN vs LNTH vs CRVL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
INGN logoINGN
LNTH logoLNTH
CRVL logoCRVL
IndustryMedical - DevicesDrug Manufacturers - Specialty & GenericInsurance - Brokers
Market Cap$196M$5.92B$2.98B
Revenue (TTM)$351M$1.55B$941M
Net Income (TTM)$-25M$279M$106M
Gross Margin47.6%60.5%24.2%
Operating Margin-9.1%18.8%14.5%
Forward P/E17.5x33.4x
Total Debt$17M$738K$28M
Cash & Equiv.$104M$359M$171M

INGN vs LNTH vs CRVLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

INGN
LNTH
CRVL
StockMay 20May 26Return
Inogen, Inc. (INGN)10018.9-81.1%
Lantheus Holdings, … (LNTH)100662.8+562.8%
CorVel Corporation (CRVL)100256.6+156.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: INGN vs LNTH vs CRVL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LNTH leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. CorVel Corporation is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
INGN
Inogen, Inc.
The Secondary Option

INGN plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
LNTH
Lantheus Holdings, Inc.
The Long-Run Compounder

LNTH carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 41.9% 10Y total return vs CRVL's 267.5%
  • Lower volatility, beta 0.47, Low D/E 0.1%, current ratio 2.70x
  • Beta 0.47, current ratio 2.70x
Best for: long-term compounding and sleep-well-at-night
CRVL
CorVel Corporation
The Insurance Pick

CRVL is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.48
  • Rev growth 12.6%, EPS growth 24.5%, 3Y rev CAGR 11.5%
  • 12.6% revenue growth vs LNTH's 0.5%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCRVL logoCRVL12.6% revenue growth vs LNTH's 0.5%
ValueLNTH logoLNTHLower P/E (17.5x vs 33.4x)
Quality / MarginsLNTH logoLNTH18.0% margin vs INGN's -7.1%
Stability / SafetyLNTH logoLNTHBeta 0.47 vs INGN's 1.10, lower leverage
DividendsTieNone of these 3 stocks pay a meaningful dividend
Momentum (1Y)LNTH logoLNTH+13.1% vs CRVL's -47.9%
Efficiency (ROA)CRVL logoCRVL16.4% ROA vs INGN's -8.3%, ROIC 51.3% vs -24.4%

INGN vs LNTH vs CRVL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

INGNInogen, Inc.

Segment breakdown not available.

LNTHLantheus Holdings, Inc.
FY 2025
Product
33.4%$1.5B
Radiopharmaceutical Oncology
21.9%$989M
PYLARIFY
21.9%$989M
Total Precision Diagnostics
10.9%$493M
DEFINITY
7.3%$330M
Techne Lite
1.9%$87M
Strategic Partnerships And Other
1.3%$59M
Other (2)
1.3%$59M
CRVLCorVel Corporation
FY 2025
Patient Management Services
64.9%$581M
Network Solutions Services
35.1%$314M

INGN vs LNTH vs CRVL — Financial Metrics

Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLNTHLAGGINGINGN

Income & Cash Flow (Last 12 Months)

LNTH leads this category, winning 5 of 6 comparable metrics.

LNTH is the larger business by revenue, generating $1.5B annually — 4.4x INGN's $351M. LNTH is the more profitable business, keeping 18.0% of every revenue dollar as net income compared to INGN's -7.1%.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…CRVL logoCRVLCorVel Corporation
RevenueTrailing 12 months$351M$1.5B$941M
EBITDAEarnings before interest/tax-$16M$347M$168M
Net IncomeAfter-tax profit-$25M$279M$106M
Free Cash FlowCash after capex-$9M$372M$69M
Gross MarginGross profit ÷ Revenue+47.6%+60.5%+24.2%
Operating MarginEBIT ÷ Revenue-9.1%+18.8%+14.5%
Net MarginNet income ÷ Revenue-7.1%+18.0%+11.2%
FCF MarginFCF ÷ Revenue-2.6%+24.0%+7.3%
Rev. Growth (YoY)Latest quarter vs prior year+3.4%+1.2%+3.4%
EPS Growth (YoY)Latest quarter vs prior year-20.0%+76.5%+2.2%
LNTH leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

Evenly matched — INGN and LNTH each lead in 3 of 6 comparable metrics.

At 26.7x trailing earnings, LNTH trades at a 16% valuation discount to CRVL's 31.7x P/E. On an enterprise value basis, LNTH's 14.6x EV/EBITDA is more attractive than CRVL's 18.9x.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…CRVL logoCRVLCorVel Corporation
Market CapShares × price$196M$5.9B$3.0B
Enterprise ValueMkt cap + debt − cash$110M$5.6B$2.8B
Trailing P/EPrice ÷ TTM EPS-8.46x26.69x31.73x
Forward P/EPrice ÷ next-FY EPS est.17.52x33.37x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple14.61x18.88x
Price / SalesMarket cap ÷ Revenue0.56x3.84x3.33x
Price / BookPrice ÷ Book value/share1.02x5.72x9.38x
Price / FCFMarket cap ÷ FCF16.73x32.57x
Evenly matched — INGN and LNTH each lead in 3 of 6 comparable metrics.

Profitability & Efficiency

CRVL leads this category, winning 5 of 8 comparable metrics.

CRVL delivers a 28.1% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $-13 for INGN. LNTH carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to INGN's 0.09x. On the Piotroski fundamental quality scale (0–9), CRVL scores 8/9 vs LNTH's 5/9, reflecting strong financial health.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…CRVL logoCRVLCorVel Corporation
ROE (TTM)Return on equity-12.9%+24.3%+28.1%
ROA (TTM)Return on assets-8.3%+12.4%+16.4%
ROICReturn on invested capital-24.4%+30.6%+51.3%
ROCEReturn on capital employed-13.3%+17.1%+39.5%
Piotroski ScoreFundamental quality 0–9658
Debt / EquityFinancial leverage0.09x0.00x0.09x
Net DebtTotal debt minus cash-$86M-$358M-$143M
Cash & Equiv.Liquid assets$104M$359M$171M
Total DebtShort + long-term debt$17M$738,000$28M
Interest CoverageEBIT ÷ Interest expense11.72x
CRVL leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

LNTH leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LNTH five years ago would be worth $41,420 today (with dividends reinvested), compared to $1,079 for INGN. Over the past 12 months, LNTH leads with a +13.1% total return vs CRVL's -47.9%. The 3-year compound annual growth rate (CAGR) favors LNTH at -1.4% vs INGN's -15.3% — a key indicator of consistent wealth creation.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…CRVL logoCRVLCorVel Corporation
YTD ReturnYear-to-date+8.4%+35.3%-11.7%
1-Year ReturnPast 12 months+0.3%+13.1%-47.9%
3-Year ReturnCumulative with dividends-39.3%-4.0%-16.7%
5-Year ReturnCumulative with dividends-89.2%+314.2%+45.7%
10-Year ReturnCumulative with dividends-85.3%+4192.5%+267.5%
CAGR (3Y)Annualised 3-year return-15.3%-1.4%-5.9%
LNTH leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LNTH leads this category, winning 2 of 2 comparable metrics.

LNTH is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than INGN's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LNTH currently trades 97.8% from its 52-week high vs CRVL's 49.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…CRVL logoCRVLCorVel Corporation
Beta (5Y)Sensitivity to S&P 5001.10x0.47x0.48x
52-Week HighHighest price in past year$9.13$93.00$117.22
52-Week LowLowest price in past year$5.34$47.25$44.83
% of 52W HighCurrent price vs 52-week peak+78.8%+97.8%+49.5%
RSI (14)Momentum oscillator 0–10058.761.246.5
Avg Volume (50D)Average daily shares traded282K886K203K
LNTH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CRVL leads this category, winning 1 of 1 comparable metric.

Analyst consensus: INGN as "Buy", LNTH as "Buy". Consensus price targets imply 261.6% upside for INGN (target: $26) vs 11.0% for LNTH (target: $101).

MetricINGN logoINGNInogen, Inc.LNTH logoLNTHLantheus Holdings…CRVL logoCRVLCorVel Corporation
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$26.00$101.00
# AnalystsCovering analysts1117
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises01
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+5.1%+1.3%
CRVL leads this category, winning 1 of 1 comparable metric.
Key Takeaway

LNTH leads in 3 of 6 categories (Income & Cash Flow, Total Returns). CRVL leads in 2 (Profitability & Efficiency, Analyst Outlook). 1 tied.

Best OverallLantheus Holdings, Inc. (LNTH)Leads 3 of 6 categories
Loading custom metrics...

INGN vs LNTH vs CRVL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is INGN or LNTH or CRVL a better buy right now?

For growth investors, CorVel Corporation (CRVL) is the stronger pick with 12.

6% revenue growth year-over-year, versus 0. 5% for Lantheus Holdings, Inc. (LNTH). Lantheus Holdings, Inc. (LNTH) offers the better valuation at 26. 7x trailing P/E (17. 5x forward), making it the more compelling value choice. Analysts rate Inogen, Inc. (INGN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — INGN or LNTH or CRVL?

On trailing P/E, Lantheus Holdings, Inc.

(LNTH) is the cheapest at 26. 7x versus CorVel Corporation at 31. 7x. On forward P/E, Lantheus Holdings, Inc. is actually cheaper at 17. 5x.

03

Which is the better long-term investment — INGN or LNTH or CRVL?

Over the past 5 years, Lantheus Holdings, Inc.

(LNTH) delivered a total return of +314. 2%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: LNTH returned +41. 9% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — INGN or LNTH or CRVL?

By beta (market sensitivity over 5 years), Lantheus Holdings, Inc.

(LNTH) is the lower-risk stock at 0. 47β versus Inogen, Inc. 's 1. 10β — meaning INGN is approximately 135% more volatile than LNTH relative to the S&P 500. On balance sheet safety, Lantheus Holdings, Inc. (LNTH) carries a lower debt/equity ratio of 0% versus 9% for Inogen, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — INGN or LNTH or CRVL?

By revenue growth (latest reported year), CorVel Corporation (CRVL) is pulling ahead at 12.

6% versus 0. 5% for Lantheus Holdings, Inc. (LNTH). On earnings-per-share growth, the picture is similar: Inogen, Inc. grew EPS 44. 1% year-over-year, compared to -21. 8% for Lantheus Holdings, Inc.. Over a 3-year CAGR, LNTH leads at 18. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — INGN or LNTH or CRVL?

Lantheus Holdings, Inc.

(LNTH) is the more profitable company, earning 15. 2% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 15. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LNTH leads at 20. 2% versus -8. 7% for INGN. At the gross margin level — before operating expenses — LNTH leads at 61. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is INGN or LNTH or CRVL more undervalued right now?

On forward earnings alone, Lantheus Holdings, Inc.

(LNTH) trades at 17. 5x forward P/E versus 33. 4x for CorVel Corporation — 15. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for INGN: 261. 6% to $26. 00.

08

Which pays a better dividend — INGN or LNTH or CRVL?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is INGN or LNTH or CRVL better for a retirement portfolio?

For long-horizon retirement investors, CorVel Corporation (CRVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

48), +267. 5% 10Y return). Both have compounded well over 10 years (CRVL: +267. 5%, INGN: -85. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between INGN and LNTH and CRVL?

These companies operate in different sectors (INGN (Healthcare) and LNTH (Healthcare) and CRVL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

INGN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 28%
Run This Screen
Stocks Like

LNTH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

CRVL

Quality Business

  • Sector: Financial Services
  • Market Cap > $100B
  • Net Margin > 6%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform INGN and LNTH and CRVL on the metrics below

Revenue Growth>
%
(INGN: 3.4% · LNTH: 1.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.